Bamco Inc Beam Therapeutics Inc. Transaction History

Bamco Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$23.46 - $45.07 $703,800 - $1.35 Million	30,000 New	30,000 $991,000
Q1 2022 May 13, 2022	SELL	$53.73 - $82.16 $844,474 - $1.29 Million	-15,717 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$68.02 - $99.06 $183,654 - $267,462	2,700 Added 20.74%	15,717 $1.25 Million
Q3 2021 Nov 12, 2021	SELL	$84.37 - $133.6 $404,976 - $641,280	-4,800 Reduced 26.94%	13,017 $1.13 Million
Q2 2021 Aug 13, 2021	SELL	$64.12 - $128.71 $5.14 Million - $10.3 Million	-80,200 Reduced 81.82%	17,817 $2.29 Million
Q1 2021 May 19, 2021	BUY	$71.28 - $120.75 $6.99 Million - $11.8 Million	98,017 New	98,017 $7.85 Million

253

78.6M

304K

142K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $2.14B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.